yielded several minor components with antifungal activity. One of these minor components, neocopiamycin A, was isolated and characterized. The structure of neocopiamycin A was determined as N-demethylcopiamycin on the basis of spectroscopic evidence.
The antibiotic was found to be more active against Gram-positive bacteria and fungi but less toxic than copiamycin. rpm, inner pressure of 0.5 kg/cm2 and at 27°C. Time course of antibiotic production was followed by paper disc method using Candida albicans IFM 40009 as a test organism. The production of the antibiotics reached maximum after 72 hours of fermentation.
Isolation and Purification
Copiamycin group antibiotics mainly accumulated in the mycelia and were scarcely found in the culture filtrate. Thus, the mycelial cake was collected by continuous centrifugation and washed with water.
The collected wet cake, 7.8 kg, was extracted twice with 3 and 1.5 volumes of methanol successively.
The solvent extracts were combined and concentrated to one tenth of original volume under reduced pres-
sure. An equal volume of water was added to the concentrate and the mixture was extracted twice with an equal amount of 1-butanol. The extract was evaporated under reduced pressure to give a brown solid (250 g). The solid was dissolved in a small amount of methanol and chromatographed on a silica gel column (Mallincrodt Co., U.S.A.) and developed with chloroform, followed by a solvent mixture of chloroform -methanol (4: 1). Copiamycins were not found in these eluates but were found in those which were eluted with chloroform -methanol (3: 2) and (1: 1). The active eluates were combined and Table I and its skeletal structure is illustrated in The methine group bearing malonyl hemiester. Antimicrobial Activity
The minimum inhibitory concentration (MIC) of neocopiamycin A and copiamycin against bacteria, yeasts and fungi were determined by a serial two-fold agar dilution method. The medium used was Mueller-Hinton agar for bacteria and Sabouraud dextrose agar for yeasts and fungi. The antibiotics were dissolved in a small amount of ethanol and diluted with sterilized water to give final agar media containing less than one percent of the solvent, which was not a harmful concentration against the organisms tested. The MICs were determined after incubation for 24 hours or 4 days at 37°C for bacteria and 24 hours to 7 days at 37°C for yeasts and fungi, depending on the test strain.
Antimicrobial spectra of neocopiamycin A and copiarnycin are given in Tables 4, 5 and 6. The tables show that neocopiamycin A is active against a wide range of yeasts, fungi and Gram-positive bacteria but inactive against Gram-negative bacteria and that it has much higher antimicrobial activity than copiamycin. Furthermore, it should be pointed out that the antibiotic inhibits the growth of both filamentous and yeast-like fungi at concentrations below 10 /cg/ml. The growth of Trichomonas vaginalis was inhibited at the concentration of 1.56 /cg/ml in thioglycolated medium with 0.5 % dextrin and 15 bovine serum.
Toxicity
Acute toxicity of neocopiamycin A was determined with ddY mice weighing 20 to 21 g. Neocopiamycin A was finely pulverized and suspended in 10 % ethanol solution for intravenous, intraperitoneal and oral administrations. Neocopiamycin A was relatively nontoxic as follows: All mice tolerated for 14 days without any toxic signs 30 mg/kg of the antibiotic by intravenous injection and more than 1,000 mg/ml by intraperitoneal and oral administrations.
Discussion
When copiamycin was first isolated, the antibiotic was found to be sparingly soluble or insoluble in 
